OKYO
OKYO Pharma Ltd
1.50$
+9.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -54.3% | -35.2% | +0.0% | +83.5% | +0.0% | +30.0% | +0.0% | +0.0% | +26.3% | +351.7% | +0.0% | |
| – | -41.5% | -35.0% | +0.0% | +83.8% | +0.0% | +30.0% | +0.0% | +0.0% | +26.3% | +351.7% | +0.0% | |
| – | -60.0% | -48.9% | +0.0% | +19.4% | +0.0% | +58.1% | +0.0% | +0.0% | +170.4% | +245.8% | +0.0% | |
| – | -60.0% | -48.9% | +0.0% | +19.4% | +0.0% | +58.1% | +0.0% | +0.0% | +170.4% | – | – | |
| – | -49.3% | – | – | +0.0% | +160.9% | – | – | +0.0% | -98.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +305.0% | -10.8% | +0.0% | +35.5% | +0.0% | -8.2% | +0.0% | +0.0% | -12.7% | +7.2% | +0.0% | |
| – | +14.6% | -10.8% | +0.0% | +35.5% | +0.0% | -8.2% | +0.0% | +0.0% | -12.7% | +7.2% | +0.0% | |
| – | +32.2% | – | – | – | +0.0% | – | – | – | – | – | – | |
| – | – | – | +0.0% | +56.8% | -9.3% | -9.3% | +0.0% | +0.0% | -10.0% | +0.4% | +0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | +0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -99.9% | +99,900.0% | +1.8% | +0.0% | -99.9% | +86,872.8% | -8.8% | +3.9% | +40.2% | -28.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.